Differential regulation of HLA-DR expression and antigen presentation in Toxoplasma gondii-infected melanoma cells by interleukin 6 and interferon γ

Microbiology and Immunology

Volumn 40, Issue 6, 1996, Pages 443-449

  Yang, Tian Hui ^a   Aosai, Fumie ^a   Norose, Kazumi ^b   Ueda, Masakatsu ^a   Yano, Akihiko ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

IFN ; IL 6; Melanoma; Toxoplasma gondii

Indexed keywords

GAMMA INTERFERON; HLA DR3 ANTIGEN; INTERLEUKIN 6;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL SPECIFICITY; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MELANOMA; MOLECULAR CLONING; TOXOPLASMA GONDII;

TOXOPLASMA GONDII;

EID: 0029894052     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1996.tb01091.x     Document Type: Article

References (30)

1. Adams, L.B., Hibbs. J.B., Jr., Taintor, R.R., and Krahenbuhl, J.L. 1990. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii: role for synthesis of inorganic nitrogen oxides from L-arginine. J. Immunol. 144: 2725-2729.
2. Aosai, F., Yang, T.H., Ueda, M., and Yano, A. 1994. Isolation of naturally processed peptides from a Toxoplasma gondii-infected human B lymphoma cell line that are recognized by cytotoxic T lymphocytes. J. Parasitol. 80: 260-266.
3. Arcari, P., Martinelli, R., and Salvatore, F. 1984. The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res. 12: 9179-9189.
4. Beaman, M.H., Hunter, C.A., and Remington, J.S. 1994. Enhancement of intracellular replication of Toxoplasma gondii by IL-6. Interaction with IFN-γ and TNF-α. J. Immunol. 153: 4583-4587.
5. Boes, B., Hengel, H., Ruppert, T., Multhaup, G., Koszinowski, U.H., and Kloetzel, P.M. 1994. Interferon γ stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J. Exp. Med. 179: 901-909.
6. Cherwinski, H.M., Schumacher, J.H., Brown, K.D., and Mosmann, T.R. 1987. Two types of mouse helper T cell clone: III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166: 1229-1244.
7. Del Prete, G., De Carli, M., Almerigogna, F., Giudizi, M.G., Biagiotti, R., and Romagnani, S. 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150: 353-360.
8. Farrar, M.A., and Schreiber, R.D. 1993. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11: 571-611.
9. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol. 149: 175-180.
10. Gerrard, T.L., Dyer, D.R., and Mostowski, H.S. 1990. IL-4 and granulocyte-macrophage colony-stimulating factor selectively increase HLA-DR and HLA-DP antigens but not HLA-DQ antigens on human monocytes. J. Immunol. 144: 4670-4674.
11. Hawrylowicz, C.M., and Unanue, E.R. 1988. Regulation of antigen-presentation I. IFN-γ induces antigen-presenting properties on B cells. J. Immunol. 141: 4083-4088.
12. Hirano, T., Akira, S., Taga, T., and Kishimoto, T. 1990. Biological and clinical aspects of interleukin 6. Immunol. Today 11: 443-449.
13. Kuchroo, V.K., Das, M.P., Brown, J.A., Ranger, A.M., Zamvil, S.S., Sobel, R.A., Weiner, H.L., Nabavi, N., and Glimcher, L.H. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707-718.
14. + cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profiles. Int. J. Cancer 57: 56-62.
15. Mosmann, T.R., and Coffman, R.L. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145-173.
16. Ota, M., Seki, T., Fukushima, H., Tsuji, K., and Inoko, H. 1992. HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 39: 187-202.
17. Pober, J.S., Collins, T., Gimbrone, M.A., Jr., Cotran, R.S., Gitlin, J.D., Fiers, W., Clayberger, C., Krensky, A.M., Burakoff, S.J., and Reiss, C.S. 1983. Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 305: 726-729.
18. Prina, E., Jouanne, C., de Lao, S.S., Szabo, A., Guillet, J.G., and Antoine, J.C. 1993. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis Amastigotes. J. Immunol. 151: 2050-2061.
19. Rhodes, J., Ivanyi, J., and Cozens, P. 1986. Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production by using recombinant interferons and corticosteroids. Eur. J. Immunol. 16: 370-375.
20. Romagnani, S. 1992. Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int. Arch. Allergy Immunol. 98: 279-285.
21. + T cells. Annu. Rev. Imrnunol. 12: 635-673.
22. Siegrist, C.-A., Martinez-Soria, E., Kern, I., and Mach, B. 1995. A novel antigen-processing-defective phenotype in major histocompatibility complex Class II-positive CIITA transfectants is corrected by interferon γ. J. Exp. Med. 182: 1793-1799.
23. Suzuki, Y., Orellana, M.A., Schreiber, R.D., and Remington, J.S. 1988. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240: 516-518.
24. Suzuki, Y., Yang, Q., Conley, F.K., Abrams, J.S., and Remington, J.S. 1994. Antibody against interleukin-6 reduces inflammation and numbers of cysts in brains of mice with toxoplasmic encephalitis. Infect. Immunol. 62: 2773-2778.
25. Vora, M., Yssel, H., de Vries, J.E., and Karasek, M.A. 1994. Antigen presentation by human dermal microvascular endothelial cells. Immunoregulatory effect of IFN-γ and IL-10. J. Immunol. 152: 5734-5741.
26. +, class II-restricted T cells induces HT-2 cells to proliferate. J. Immunol. 138: 4293-4297.
27. + cytotoxic T lymphocytes specific for T. gondii-infected human melanoma cells. J. Immunol. 154: 290-298.
28. + cytotoxic cells. J. Parasitol. 75: 411-416.
29. Yano, A., Ohno, S., Norose, K., Baba, K., Yamashita, K., Aosai, F., and Segawa, F. 1992. Antigen presentation by Toxoplasma-infected cells: antigen entry through cell membrane fusion. Int. Arch. Allergy Immunol. 98: 13-17.
30. Yong, E.C., Chi, E.Y., and Henderson W.R., Jr. 1994. Toxoplasma gondii alters eicosanoid release by human mononuclear phagocytes: role of leukotrienes in interferon γ-induced antitoxoplasma activity. J. Exp. Med. 180: 1637-1648.